Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors

被引：0
|
作者：
Christina Darden
Mark Price
David Ray
Grace Goldstein
Diana Goss
Lee Bennett
Diana Garbinsky
Ramya Thota
机构：
[1] RTI Health Solutions,Department of Surveys and Observational Studies
[2] Ipsen Biopharmaceuticals,Department of Patient
[3] Inc.,Reported Outcomes
[4] Carcinoid Cancer Foundation,Department of Biometrics
[5] RTI Health Solutions,undefined
[6] RTI Health Solutions,undefined
[7] Intermountain Medical Center,undefined
来源：
Journal of Patient-Reported Outcomes | / 5卷
关键词：
Neuroendocrine tumor; Serial survey; Patient experience; Satisfaction; Interviews; Somatostatin analog;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] DEVELOPMENT OF RESISTANCE TO A LONG-ACTING SOMATOSTATIN ANALOG DURING TREATMENT OF 2 PATIENTS WITH METASTATIC ENDOCRINE PANCREATIC TUMORS
    LAMBERTS, SWJ
    PIETERS, GFFM
    METSELAAR, HJ
    ONG, GL
    TAN, HS
    REUBI, JC
    ACTA ENDOCRINOLOGICA, 1988, 119 (04): : 561 - 566
  • [42] AGGRAVATION OF HYPOGLYCEMIA IN INSULINOMA PATIENTS BY THE LONG-ACTING SOMATOSTATIN ANALOG OCTREOTIDE (SANDOSTATIN)
    STEHOUWER, CDA
    LEMS, WF
    FISCHER, HRA
    HACKENG, WHL
    NAAFS, MAB
    ACTA ENDOCRINOLOGICA, 1989, 121 (01): : 34 - 40
  • [43] Satisfaction of patients and caregivers with long-acting injectable risperidone and oral atypical antipsychotics
    Han, CS
    Lee, BH
    Kim, YK
    Lee, HJ
    Kim, SH
    Kim, L
    Lee, MS
    Joe, SH
    Ham, BJ
    Jung, IK
    PRIMARY CARE & COMMUNITY PSYCHIATRY, 2005, 10 (03) : 119 - 124
  • [44] The treatment of neuroendocrine tumors with long-acting somatostatin analogs: A single center experience with lanreotide autogel
    Bianchi, A.
    De Marinis, L.
    Fusco, A.
    Lugli, F.
    Tartaglione, L.
    Milardi, D.
    Mormando, M.
    Lassandro, A. P.
    Paragliola, R.
    Rota, C. A.
    Della Casa, S.
    Corsello, S. M.
    Brizi, M. G.
    Pontecorvi, A.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2011, 34 (09) : 692 - 697
  • [45] The treatment of neuroendocrine tumors with long-acting somatostatin analogs: A single center experience with lanreotide autogel
    A. Bianchi
    L. De Marinis
    A. Fusco
    F. Lugli
    L. Tartaglione
    D. Milardi
    M. Mormando
    A. P. Lassandro
    R. Paragliola
    C. A. Rota
    S. Della Casa
    S. M. Corsello
    M. G. Brizi
    A. Pontecorvi
    Journal of Endocrinological Investigation, 2011, 34 : 692 - 697
  • [46] Long-acting depot lanreotide in the treatment of patients with advanced neuroendocrine tumors
    Ricci, S
    Antonuzzo, A
    Galli, L
    Orlandini, C
    Ferdeghini, M
    Boni, G
    Roncella, M
    Mosca, F
    Conte, PF
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2000, 23 (04): : 412 - 415
  • [47] SOMATOSTATIN ANALOG THERAPY IN FUNCTIONING NEUROENDOCRINE GUT TUMORS
    DEBAS, HT
    GITTES, G
    DIGESTION, 1993, 54 : 68 - 71
  • [48] LONG-TERM TREATMENT OF ACROMEGALY WITH A LONG-ACTING ANALOG OF SOMATOSTATIN
    CHNG, LJC
    SANDLER, LM
    KRAENZLIN, ME
    BURRIN, JM
    JOPLIN, GF
    BLOOM, SR
    BRITISH MEDICAL JOURNAL, 1985, 290 (6464): : 284 - 285
  • [49] OCTREOTIDE, A LONG-ACTING SOMATOSTATIN ANALOG, IN DIABETIC NEUROPATHIC PAIN
    CHAN, AW
    WILLIAMS, G
    MACFARLANE, IA
    BOWSHER, D
    HORMONE RESEARCH, 1991, 36 (1-2) : 86 - 87
  • [50] PHARMACOKINETICS AND EFFICACY OF THE LONG-ACTING SOMATOSTATIN ANALOG SOMATULINE IN ACROMEGALY
    JOHNSON, MR
    CHOWDREY, HS
    THOMAS, F
    GRINT, C
    LIGHTMAN, SL
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1994, 130 (03) : 229 - 234
12345